Capitalizes on Company\'s APAC Growth Momentum CHANGSHU,China,Jan. 15,2025-- Nexteer Automotive today announced the grand opening of its new facility in Changshu,Jiangsu Province,as a strategic expan
Jan 16, 2025
NPST\'s innovative technology underscores its commitment to advancing digital payment adoption to meet diverse user needs,and its strategic adaptability establishes it as a pivotal player in India\'s
Jan 16, 2025
SINGAPORE,Jan. 15,2025--In a world increasingly driven by artificial intelligence and complex computations,tackling the most challenging problems—from modeling galaxies to designing personalized med
Jan 16, 2025
Realize the Dream,launched on MLK Day 2024,will create 100 million hours of community service by the 100th anniversary of Dr. Martin Luther King,Jr.\'s birth in 2029
Jan 16, 2025
DUBAI,UAE,Jan. 15,2025-- Nakheel,a member of Dubai Holding Real Estate,has announced its collaboration with six locally and globally acclaimed architecture firms – WATG,SAOTA,Whitespace Architects,NA
Jan 16, 2025
SEOUL,South Korea,Jan. 15,2025-- NEXTBIOMEDICAL CO.,LTD,a KOSDAQ-listed innovative medical device company in South Korea,proudly announced that it has received Investigational Device Exemption (IDE)
Jan 16, 2025
New modular analytics solution empowers commercial teams to optimize strategies and improve patient outcomes
Jan 15, 2025
PISCATAWAY,N.J.,Jan. 14,2025-- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packa
Jan 15, 2025
Simplifying payments for both domestic and international tourists MACAO,Jan. 14,2025--On Jan. 14,2025,Sands China Ltd.,Alipay and Macau Pass jointly introduced the Alipay Tap! service at Sands Resorts
Jan 15, 2025
Aiming to export 2 MTPA of green fuels,this partnership positions India as a leader in global decarbonization efforts.
Jan 15, 2025
LAS VEGAS,Jan. 14,2025-- During CES 2025,Microsoft Greater China held a specialized event themed "Be AI Ready,Win Globally," focusing on empowering Chinese enterprises that are expanding in
Jan 15, 2025
SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch
Jan 15, 2025
© Singapore Technology Information Privacy Policy Contact us